Getting access to drugs for Canadians is Farah’s passion. Her drive and energy to strive for success has led to a track record in securing funding for new prescription drugs in Canada for large multinational pharmaceutical companies.
As a reimbursement and health economic strategist with 15 years of experience, Farah is recognized as a collaborative team leader with international experience who develops and articulates new product value propositions and successfully negotiates platforms.
She leads and empowers teams to influence policy and negotiate adoption and access through governments and insurers.
Specialties: Therapeutic area expertise includes Oncology, Immunology, virology and metabolics.Key areas of expertise include reimbursement, pricing strategy, health economics and health outcomes, government and stakeholder relations, listing agreements and provincial and private negotiation strategies.Back to Board of Directors